{"nct_id":"NCT04049617","title":"Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2022-09","start_date":"2019-08-26","start_date_type":"ACTUAL","primary_completion_date":"2021-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}